ATE111525T1 - Plasminogenaktivator-varianten und verfahren zu ihrer herstellung. - Google Patents

Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.

Info

Publication number
ATE111525T1
ATE111525T1 AT89906612T AT89906612T ATE111525T1 AT E111525 T1 ATE111525 T1 AT E111525T1 AT 89906612 T AT89906612 T AT 89906612T AT 89906612 T AT89906612 T AT 89906612T AT E111525 T1 ATE111525 T1 AT E111525T1
Authority
AT
Austria
Prior art keywords
plasminogen activator
variants
manufacture
processes
glycosylated
Prior art date
Application number
AT89906612T
Other languages
English (en)
Inventor
Stephen Anderson
Bruce Keyt
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE111525T1 publication Critical patent/ATE111525T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89906612T 1988-05-20 1989-05-04 Plasminogenaktivator-varianten und verfahren zu ihrer herstellung. ATE111525T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19690988A 1988-05-20 1988-05-20

Publications (1)

Publication Number Publication Date
ATE111525T1 true ATE111525T1 (de) 1994-09-15

Family

ID=22727245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906612T ATE111525T1 (de) 1988-05-20 1989-05-04 Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.

Country Status (12)

Country Link
EP (1) EP0424405B1 (de)
JP (1) JP2928798B2 (de)
AT (1) ATE111525T1 (de)
AU (1) AU624158B2 (de)
CA (1) CA1341432C (de)
DE (1) DE68918279T2 (de)
DK (1) DK175938B1 (de)
ES (1) ES2013500A6 (de)
HK (1) HK1007333A1 (de)
IL (1) IL90146A (de)
NZ (1) NZ229081A (de)
WO (1) WO1989011531A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098840A (en) * 1986-07-03 1992-03-24 The Green Cross Corporation Human prourokinase mutants
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
NO894967L (no) * 1988-12-12 1990-06-13 Yamanouchi Pharma Co Ltd Fremgangsmaate for fremstilling av nye thrombolytiske proteiner.
JPH0387180A (ja) * 1989-05-18 1991-04-11 Green Cross Corp:The 変異ヒトプロウロキナーゼ、その製法、ｄｎａ配列、プラスミド、宿主
DK0542869T3 (da) * 1990-07-31 1996-02-05 Genentech Inc Vævsplasminogenaktivatorvarianter med nedsat udskillelse
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
DK0643772T3 (da) 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
EP1711533B1 (de) * 2004-01-14 2013-12-11 Ohio University Verfahren zur Herstellung von Peptiden/Proteinen in Pflanzen und dadurch hergestellte Peptide/Proteine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
AU7090787A (en) * 1986-02-19 1987-10-08 Beecham Group Plc Tissue plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
DE68918279T2 (de) 1995-03-23
AU3744889A (en) 1989-12-12
NZ229081A (en) 1991-03-26
EP0424405A1 (de) 1991-05-02
DK274990D0 (da) 1990-11-19
HK1007333A1 (en) 1999-04-09
IL90146A (en) 1994-10-07
EP0424405B1 (de) 1994-09-14
DK274990A (da) 1991-01-18
ES2013500A6 (es) 1990-05-01
DK175938B1 (da) 2005-07-25
AU624158B2 (en) 1992-06-04
IL90146A0 (en) 1989-12-15
CA1341432C (en) 2003-06-17
JP2928798B2 (ja) 1999-08-03
WO1989011531A1 (en) 1989-11-30
JPH03504327A (ja) 1991-09-26
DE68918279D1 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
NL970008I2 (nl) Derivaat van een weefselplasminogeenactivator.
ATE111525T1 (de) Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.
NO178687C (no) Fremgangsmåte for fremstilling av forenlige, lagringsstabile erythropoietinpreparater
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
DK288183A (da) Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
PT80300A (de) Herstellung von polypeptiden mit human-gammainterferonaktivitat
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
Zeldin et al. Acrylamide electrophoresis and protein pattern during morphogenesis in a slime mould
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
ATE114477T1 (de) Chemisch modifizierte allergene und verfahren zu ihrer herstellung.
DE3689921D1 (de) Menschlicher plazentarer angiogenischer Faktor, geeignet für die Reizung der Kapillarsynthese, der Endothelzellprotease, der DNS-Synthese und der Absiedlung.
DK0542869T3 (da) Vævsplasminogenaktivatorvarianter med nedsat udskillelse
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time